Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.
Estimates the potential benefit of ovarian function suppression based on a composite recurrence risk score.
Select patient age, nodal involvement, tumor size, histologic grade, and ER/PR/Ki-67 expression levels.
This resource is intended for educational purposes only and is intended for US healthcare professionals. Healthcare professionals should use independent medical judgment. All decisions regarding patient care must be handled by a healthcare professional and be made based on the unique needs of each patient.